Clinical Trials
2 trialsNCT06745583 2026-06-03
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Phase 2 Recruiting
NCT07614243 2026-05-29
ZFAS1-BIPN
The First Affiliated Hospital of Zhejiang Chinese Medical University
Phase NA Completed